Greg Pyszczymuka Aytu Biopharma, Inc (AYTU) insider trading activity

Greg Pyszczymuka is Chief Commercial Officer of AYTU BIOPHARMA, INC. Currently has a direct ownership of 23,602 shares of AYTU, which is worth approximately $53,812. The most recent transaction as insider was on Mar 31, 2025, when has been sold 209 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.6K

0% 3M change

2.72% 12M change

Total Value Held $53,812

GREG PYSZCZYMUKA Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2025	BUY Exercise of conversion of derivative security	-	209 Added 0.88%	23,602 Common Shares
Dec 31 2024	BUY Exercise of conversion of derivative security	-	208 Added 0.88%	23,393 Common Shares
Sep 30 2024	BUY Exercise of conversion of derivative security	-	209 Added 0.89%	23,185 Common Shares
Jun 30 2024	BUY Exercise of conversion of derivative security	-	208 Added 0.9%	22,976 Common Shares
Mar 31 2024	BUY Exercise of conversion of derivative security	-	208 Added 0.91%	22,768 Common Shares
Dec 31 2023	BUY Exercise of conversion of derivative security	-	209 Added 0.92%	22,560 Common Shares
Sep 30 2023	BUY Exercise of conversion of derivative security	-	208 Added 0.92%	22,351 Common Shares
Jun 30 2023	BUY Exercise of conversion of derivative security	-	208 Added 0.93%	22,143 Common Shares
Jun 16 2023	BUY Open market or private purchase	$22,440 $1.87 p/Share	12,000 Added 35.36%	21,935 Common Shares
Apr 25 2023	BUY Exercise of conversion of derivative security	-	833 Added 7.74%	9,935 Common Shares
Dec 19 2022	BUY Open market or private purchase	$24,000 $0.24 p/Share	100,000 Added 35.45%	182,056 Common Stock

Also insider at

EVOK

Evoke Pharma Inc Healthcare